Ruey‐Kuen Hsieh

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response

Evandro de Azambuja, Andrew Holmes, Martine Piccart et al. · The Lancet Oncology · 2014 · 455 citations

Medicine, Oncology, Pharmacology +15

A correlational study of suicidal ideation with psychological distress, depression, and demoralization in patients with cancer

Chun-Kai Fang, Ming-Chih Chang, Pei-Jan Chen et al. · Supportive Care in Cancer · 2014 · 217 citations · Full text

Social Sciences, Oncology, Psychology +17

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

J.S. Chen, Chih‐Hung Hsu, Nai‐Jung Chiang et al. · Annals of Oncology · 2015 · 158 citations

Medicine, Oncology, Cancer Genetics +10

Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Chiun Hsu, Tsai‐Sheng Yang, Teh‐Ia Huo et al. · Journal of Hepatology · 2012 · 97 citations

Medicine, Oncology, Pharmacology +14

Quality of life of breast and cervical cancer survivors

Huei-Ying Huang, Wen‐Chen Tsai, Wen-Yu Chou et al. · BMC Women s Health · 2017 · 76 citations · Full text

Medicine, Geriatric Medicine, Oncology +13